Steinmetz C, Mader I, Arndt S, Aschendorff A, Laszig R, Hassepass F
Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Centre Freiburg, Killianstr. 5, 79106, Freiburg, Germany.
Eur Arch Otorhinolaryngol. 2014 Jul;271(7):2079-82. doi: 10.1007/s00405-014-3001-y. Epub 2014 Mar 18.
The new transcutaneous bone conduction implant (BCI) Bonebridge (BB, MED-EL) allows the skin to remain intact and therefore overcomes some issues related to percutaneous systems, such as skin reaction around the external screw and cosmetic complaints. According to manufacturer, BB is MRI conditional up to 1,5 Tesla (T). The artefact of the neurocranium after BB implantation is extensive as shown in the present report. This has to be taken into account when patients suffering conductive, mixed or single-sided hearing loss with candidacy for a BCI are counselled. In patients with comorbid intracranial tumour or other diseases of the brain that require imaging control scans with MRI percutaneous, BCI should be the implant of choice considering the very small artefact of the percutaneous screw in MRI.
新型经皮骨传导植入物(BCI)骨桥(BB,美迪乐公司)可使皮肤保持完整,因此克服了一些与经皮系统相关的问题,如外部螺钉周围的皮肤反应和美观方面的问题。根据制造商的说法,骨桥在高达1.5特斯拉(T)的磁场强度下符合磁共振成像(MRI)条件。如本报告所示,植入骨桥后神经颅骨的伪影范围较大。在为患有传导性、混合性或单侧听力损失且适合植入骨传导植入物的患者提供咨询时,必须考虑到这一点。对于合并颅内肿瘤或其他需要进行MRI经皮成像对照扫描的脑部疾病患者,考虑到经皮螺钉在MRI中的伪影非常小,骨传导植入物应是首选植入物。